CVS Q2 FY26 GAAP EPS more than doubled to $2.31; revenue rises 7.3% to $106.1 billion
CVS•Full-year outlook raised
- Raised full-year 2026 GAAP diluted EPS view to USD 6.84-7.04; adjusted EPS to USD 7.9-8.1, cash flow from operations to at least USD 11.5 billion.
CVS reports higher Q2 revenue and earnings
- CVS Health Q2 2026 revenue rose 7.3% to USD 106.1 billion; GAAP diluted EPS more than doubled to USD 2.31.
- GAAP operating income climbed 97.5% to USD 4.7 billion; GAAP net income rose to USD 3 billion.
- Adjusted EPS increased to USD 2.58, driven primarily by improved adjusted operating income in Health Care Benefits.
- Health Care Benefits medical benefit ratio narrowed 2.5 percentage points to 87.4%; segment adjusted operating income rose to USD 2.43 billion.
Related News
Worthington Enterprises CFO Colin Souza joins Canaccord Genuity Annual Growth Conference fireside chat
WOR•
V2X Awarded $87 Million Contract To Enhance SUU-79 Pylons For F/A-18 And EA-18G Aircraft
VVX•
